Clinical Trial Update: Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and effects of MN-221 in adults with moderate to severe asthma; the study is completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MN-221

Snippet

Sponsor: MediciNova | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2011-12-15